Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N1-((2S,5S)-5-((S)-1-((S)-1-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)-1-(4-hydroxyphenyl)-10-imino-3,12,19-trioxo-4,9,11,13,18-pentaazahenicosan-2-yl)-N8-((6S,9S,12S,15S)-1-amino-6-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)-12-(3-guanidinopropyl)-16-(4-hydroxyphenyl)-1-imino-9-isobutyl-8,11,14-trioxo-2,7,10,13-tetraazahexadecan-15-yl)octanediamide
ID: ALA3787713
Chembl Id: CHEMBL3787713
PubChem CID: 127030359
Max Phase: Preclinical
Molecular Formula: C88H136N26O18
Molecular Weight: 1846.22
Molecule Type: Small molecule
Associated Items: